ICAM1 and cholangiocarcinoma: Moreover, we also evaluated the endocytosis efficiency of the ICAM1 monoclonal antibody (clone: R6.5) used to construct ADCs in four human CCA cell lines (QBC939, SK-CHa-1, TFK-1, and HCCC-9810).